Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT

Genitourinary Cancer

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

Prostate Cancer Prostatic Dis.

Nguyen PL, Martin NE, Choeurng V, Palmer-Aronsten B, Kolisnik T, Beard CJ, Orio PF, Nezolosky MD, Chen YW, Shin H, Davicioni E, Feng FY

doi: 10.1038/pcan.2016.58.

Genitourinary Cancer

Therapy Management of Metastatic Prostate Carcinoma in General Practice

healthbook TIMES Oncology Hematology

Meisel A

doi: 10.36000/hbT.OH.2019.01.004

Genitourinary Cancer

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Alexander Meisela,b

doi: 10.36000/hbT.OH.2019.02.007

Genitourinary Cancer

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

Eur Urol.

Annala M, Struss WJ, Warner EW, Beja K, Vandekerkhove G, Wong A, Khalaf D, Seppälä IL, So A, Lo G, Aggarwal R, Small EJ, Nykter M, Gleave ME, Chi KN, Wyatt AW

doi: 10.1016/j.eururo.2017.02.023.

Breast CancerGastrointestinal CancerGenitourinary Cancer

Pulmonary metastasis as sole manifestation of relapse in previously treated localised prostate cancer: three exceptional case reports

Ecancermedicalscience.

Gago JP, Câmara G, Dionísio J, Opinião A

doi: 10.3332/ecancer.2016.645.

Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report

Urol J.

Atag E, Semiz HS, Kazaz SN, Tuna EB, Ozdogan O, Bozkurt O, Demir O, Karaoglu A

Genitourinary CancerRadio-Oncology

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

Urol Case Rep.

Bandini M, Gandaglia G, Fossati N, Montorsi F, Briganti A

doi: 10.1016/j.eucr.2017.02.011.

Radio-Oncology

Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports

J Breast Cancer.

Byun KD, Ahn SG, Baik HJ, Lee A, Bae KB, An MS, Kim KH, Shin JH, Park HK, Cho H, Jeong J, Kim TH.

doi: 10.4048/jbc.2016.19.2.214.

Genitourinary Cancer

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

BJU Int.

Loeb S, Shin SS, Broyles DL, Wei JT, Sanda M, Klee G, Partin AW, Sokoll L, Chan DW, Bangma CH, van Schaik RHN, Slawin KM, Marks LS, Catalona WJ

doi: 10.1111/bju.13676.

Related content

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

Therapy Management of Metastatic Prostate Carcinoma in General Practice

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer

Pulmonary metastasis as sole manifestation of relapse in previously treated localised prostate cancer: three exceptional case reports

Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer